Regulation of ATM/p53-dependent suppression of myc-induced lymphomas by Wip1 phosphatase

Journal of Experimental Medicine

Volumn 203, Issue 13, 2006, Pages 2793-2799

  Shreeram, Sathyavageeswaran ^a   Weng, Kee Hee ^a   Demidov, Oleg N ^a   Kek, Calvina ^a   Yamaguchi, Hiroshi ^b   Fornace Jr , Albert J ^c   Anderson, Carl W ^d   Appella, Ettore ^b   Bulavin, Dmitry V ^a  

^a INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^b NATIONAL CANCER INSTITUTE   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d BROOKHAVEN NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARF PROTEIN; ATM PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; MYC PROTEIN; PHOSPHATASE; PROTEIN P53; UNCLASSIFIED DRUG; WIP1 PHOSPHATASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; B CELL LYMPHOMA; CANCER INHIBITION; CONTROLLED STUDY; GENE CONTROL; GENE DELETION; GENE REPRESSION; GENETIC CROSS; MOUSE; NONHUMAN; PRIORITY JOURNAL; UPREGULATION;

ANIMALS; APOPTOSIS; B-LYMPHOCYTES; BLOTTING, WESTERN; CASPASES; CELL CYCLE PROTEINS; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA-BINDING PROTEINS; GENE EXPRESSION; HEAT-SHOCK PROTEINS; LYMPHOMA; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; MICE, TRANSGENIC; MODELS, BIOLOGICAL; NEOPLASM PROTEINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-MYC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 33845893896     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20061563     Document Type: Article

References (26)

1. Kastan, M.B., and J. Bartek. 2004. Cell-cycle checkpoints and cancer. Nature. 432:316-323.
2. Bartkova, J., Z. Horejsi, K. Koed, A. Kramer, F. Tort, K. Zieger, P. Guldberg, M. Sehested, J.M. Nesland, C. Lukas, et al. 2005. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature. 434:864-870.
3. Barlow, C., S. Hirotsune, R. Paylor, M. Liyanage, M. Eckhaus, F. Collins, Y. Shiloh, J.N. Crawley, T. Ried, D. Tagle, and A. Wynshaw-Boris. 1996. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell. 86:159-171.
4. Shiloh, Y., and M.B. Kastan. 2001. ATM: genome stability, neuronal development, and cancer cross paths. Adv. Cancer Res. 83:209-254.
5. Goodarzi, A.A., J.C. Jonnalagadda, P. Douglas, D. Young, R. Ye, G.B. Moorhead, S.P. Lees-Miller, and K.K. Khanna. 2004. Autophosphorylation of ataxia-telangiectasia mutated is regulated by protein phosphatase 2A. EMBO J. 23:4451-4461.
6. Shreeram, S., O.N. Demidov, W.K. Hee, H. Yamaguchi, N. Onishi, C. Kek, O.N. Timofeev, C. Dungeon, A.J. Fornace, C.W. Anderson, et al. 2006. Wip1 phosphatase modulates ATM-dependent signaling pathways. Mol. Cell. 23:757-764.
7. Bulavin, D.V., O.N. Demidov, S. Saito, P. Kauraniemi, C. Phillips, S.A. Amundson, C. Ambrosino, G. Sauter, A.R. Nebreda, C.W. Anderson, et al. 2002. Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity. Nat. Genet. 31:210-215.
8. Li, J., Y. Yang, Y. Peng, R.J. Austin, W.G. van Eyndhoven, K.C.Q. Nguyen, T. Gabriele, M.E. McCurrach, J.R. Marks, T. Hoey, et al. 2002. Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23. Nat. Genet. 31:133-134.
9. Takekawa, M., M. Adachi, A. Nakahata, I. Nakayama, F. Itoh, H. Tsukuda, Y. Taya, and K. Imai. 2000. p53-inducible Wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation. EMBO J. 19:6517-6526.
10. Arf pathway. Nat. Genet. 36:343-350.
11. Yamaguchi, H., G. Minopoli, O.N. Demidov, D.K. Chatterjee, C.W. Anderson, S.R. Durell, and E. Appella. 2005. Substrate specificity of the human protein phosphatase 2Cδ, Wip1. Biochemistry. 44:5285-5294.
12. Lu, X., B. Nannenga, and L.A. Donehower. 2005. PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints. Genes Dev. 19:1162-1174.
13. Fujimoto, H., N. Onishi, N. Kato, M. Takekawa, X.Z. Xu, A. Kosugi, T. Kondo, I. Oishi, A. Yoda, M. Imamura, and Y. Minami. 2006. Regulation of the anti-oncogenic Chk2 kinase by the oncogenic Wip1 phosphatase. Cell Death Differ. 13:1170-1180.
14. Kozlov, S., N. Gueven, K. Keating, J. Ramsay, and M.F. Lavin. 2003. ATP activates ataxia-telangiectasia mutated (ATM) in vitro. J. Biol. Chem. 278:9309-9317.
15. Kozlov, S.V., M.E. Graham, C. Peng, P. Chen, P.J. Robinson, and M.F. Lavin. 2006. Involvement of novel autophosphorylation sites in ATM activation. EMBO J. 25:3504-3514.
16. Pellegrini, M., A. Celeste, S. Difilippantonio, R. Guo, W. Wang, L. Feigenbaum, and A. Nussenzweig. 2006. Autophosphorylation at serine 1987 is dispensable for murine ATM activation in vivo. Nature. 443:222-225.
17. Adams, J.M., A.W. Harris, C.A. Pinkert, L.M. Corcoran, W.S. Alexander, S. Cory, R.D. Palmiter, and R.L. Brinster. 1985. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature. 318:533-538.
18. Schmitt, C.A., M.E. McCurrach, E. de Stanchina, R.R. Wallace-Brodeur, and S.W. Lowe. 1999. INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53. Genes Dev. 13:2670-2677.
19. Eischen, C.M., J.D. Weber, M.F. Roussel, C.J. Sherr, and J.L. Cleveland. 1999. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes Dev. 13:2658-2669.
20. Egle, A., A.W. Harris, P. Bouillet, and S. Cory. 2004. Bim is a suppressor of Myc-induced mouse B cell leukemia. Proc. Natl. Acad. Sci. USA. 101:6164-6169.
21. Smith, G.C., F. d'Adda di Fagagna, N.D. Lakin, and S.P. Jackson. 1999. Cleavage and inactivation of ATM during apoptosis. Mol. Cell. Biol. 19:6076-6084.
22. Hotti, A., K. Järvinen, P. Siivola, and E. Hölttä. 2000. Caspases and mitochondria in c-Myc-induced apoptosis: identification of ATM as a new target of caspases. Oncogene. 19:2354-2362.
23. Ramiro, A.R., M. Jankovic, E. Callen, S. Difilippantonio, H.T. Chen, K.M. McBride, T.R. Eisenreich, J. Chen, R.A. Dickins, S.W. Lowe, et al. 2006. Role of genomic instability and p53 in AID-induced c-myc-Igh translocations. Nature. 440:105-109.
24. Li, Y., D. Wu, B. Chen, A. Ingram, L. He, L. Liu, D. Zhu, A. Kapoor, and D. Tang. 2004. ATM activity contributes to the tumor-suppressing functions of p14ARF. Oncogene. 23:7355-7365.
25. Eymin, B., P. Claverie, C. Salon, C. Leduc, E. Col, E. Brambilla, S. Khochbin, and S. Gazzeri. 2006. p14ARF activates a Tip60-dependent and p53-independent ATM/ATR/CHK pathway in response to genotoxic stress. Mol. Cell. Biol. 26:4339-4350.
26. Powers, J.T., S. Hong, C.N. Mayhew, P.M. Rogers, E.S. Knudsen, and D.G. Johnson. 2004. E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis. Mol. Cancer Res. 2:203-214.